An extraordinary form of the Melkersson-Rosenthal syndrome successfully treated with the tumour necrosis factor-α blocker adalimumab | BMJ Case Reports
Cureus | Erythema Dyschromicum Perstans After Adalimumab Treatment
Potential predictive biomarkers of adalimumab response in patients with hidradenitis suppurativa* - Cao - 2021 - British Journal of Dermatology - Wiley Online Library
Early administration of adalimumab for paediatric uveitis due to Behçet's disease | Pediatric Rheumatology | Full Text
Full article: Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease
Annular Elastolytic Giant Cell Granuloma Successfully Treated With Adalimumab Subsequently Complicated by Drug-Induced Lupus - JDDonline - Journal of Drugs in Dermatology
Extensive Nevus Comedonicus with Inflammatory Nodules and Cysts Controlled with Adalimumab
Dermatologic Therapy: Vol 33, No 3
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Amgen Allowing Commercialization Of AMGEVITA™ - iData Research
Overview of Humira® Biosimilars: Current European Landscape and Future Implications - Journal of Pharmaceutical Sciences
View Image
Chronic verrucous sarcoidosis associated with human papillomavirus infection: Improvement with adalimumab | Semantic Scholar
Guselkumab Effective for Treatment of Moderate-to-Severe Plaque Psoriasis
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial - ScienceDirect
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial - The Lancet
HUMIRA (adalimumab) Hidradenitis Suppurativa Clinical Data
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966 | Scientific Reports
Protect at all costs: How the maker of the world's bestselling drug keeps prices sky-high | Fortune
Excimer Laser Therapy for Hairline Psoriasis: A Useful Addition to the Scalp Psoriasis Treatment Algorithm
Adalimumab for Refractory Folliculitis Decalvans. — Donovan Hair Clinic
Phototherapy remains a valuable psoriasis treatment
ESPRIT: 10-year post-marketing surveillance registry of adalimumab for moderate to severe psoriasis: All treatment-emergent mali
Refractory dissecting Cellulitis of the Scalp Successfully controlled with Adalimumab. | Semantic Scholar